Thromboembolism News and Research

RSS
Outcome's TotalQuality Reporting Service to help hospitals meet quality elements of Meaningful Use reporting

Outcome's TotalQuality Reporting Service to help hospitals meet quality elements of Meaningful Use reporting

JTH publishes positive TB-402 Phase II trial results for VTE treatment after orthopaedic surgery

JTH publishes positive TB-402 Phase II trial results for VTE treatment after orthopaedic surgery

Neurologic and neurosurgical patients do not receive therapy to prevent VTE: Study

Neurologic and neurosurgical patients do not receive therapy to prevent VTE: Study

Genetic testing for inherited blood-clotting abnormalities not routinely recommended for VTE patients

Genetic testing for inherited blood-clotting abnormalities not routinely recommended for VTE patients

DE-MRI holds promise for predicting risks of strokes

DE-MRI holds promise for predicting risks of strokes

Enrollment stopped in one of two global necitumumab Phase III studies in NSCLC

Enrollment stopped in one of two global necitumumab Phase III studies in NSCLC

Elsevier announces publication of two position statements from EMAS in Maturitas journal

Elsevier announces publication of two position statements from EMAS in Maturitas journal

Research sheds new light on venous thromboembolism following liver resections

Research sheds new light on venous thromboembolism following liver resections

Positive results from large, multi-center Canadian trial with On-X Prosthetic Heart Valve

Positive results from large, multi-center Canadian trial with On-X Prosthetic Heart Valve

New analysis of Soliris in patients with PNH presented at ASH Annual Meeting

New analysis of Soliris in patients with PNH presented at ASH Annual Meeting

New research focusing on VTE presented at ASH Annual Meeting

New research focusing on VTE presented at ASH Annual Meeting

Study: REVLIMID and dexamethasone for high-risk smoldering multiple myeloma reduce risk of disease progression

Study: REVLIMID and dexamethasone for high-risk smoldering multiple myeloma reduce risk of disease progression

Caprini Risk Model helps predict VTE risk in patients undergoing plastic surgery

Caprini Risk Model helps predict VTE risk in patients undergoing plastic surgery

Bristol-Myers Squibb, Pfizer discontinue Phase 3 APPRAISE-2 trial in patients with ACS

Bristol-Myers Squibb, Pfizer discontinue Phase 3 APPRAISE-2 trial in patients with ACS

Researchers hope to prevent VTE complication in cancer patients

Researchers hope to prevent VTE complication in cancer patients

Covidien granted FDA 510(k) clearance for Kendall SCD Sleeve and Kendall SCD 700 Series Controller

Covidien granted FDA 510(k) clearance for Kendall SCD Sleeve and Kendall SCD 700 Series Controller

Venous Disease Coalition launches new VTE Toolkit for health professionals

Venous Disease Coalition launches new VTE Toolkit for health professionals

New guideline for using ESAs drugs in cancer patients

New guideline for using ESAs drugs in cancer patients

New Canadian Cardiovascular Society guidelines support clinicians in practicing evidence-based medicine

New Canadian Cardiovascular Society guidelines support clinicians in practicing evidence-based medicine

Venous thromboembolism drugs to experience robust growth by 2019

Venous thromboembolism drugs to experience robust growth by 2019